AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3364403
Drug: Ca citrate
RxNorm normalized name: CALCIUM 200MG (CA CITRATE-950MG) TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca citrate (750 mg)
Trial: 3364403
Drug: Ca(H2PO4)2 (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ca(H2PO4)2 (750 mg)
Trial: 25359444
Drug: Control (fifteen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (fifteen 40‐minute sessions of transcutaneous electrical nerve stimulation, microwave treatment, and standardized exercises)
Trial: 25359444
Drug: GDS‐G (eleven
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GDS‐G (eleven 50‐minute group GDS sessions)
Trial: 23771800
Drug: PM00104 (Zalypsis)
RxNorm normalized name: Zalypsis
DrugBank: Zalypsis (DB12454)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PM00104 (Zalypsis) administered as a 1-h, weekly, intravenous infusion at a dose of 2 mg/m2 (days 1, 8, and 15; every 4 weeks)
Trial: 16551142
Drug: Drug court
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug court with usual community services
Trial: 16551142
Drug: Drug court
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug court with multisystemic therapy
Trial: 16551142
Drug: Drug court
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug court with multisystemic therapy enhanced with contingency management
Trial: 14607573
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid (5 mg) and zinc sulfate (66 mg)
Trial: 10892657
Drug: L-arginine (20-g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (20-g oral dose)
Trial: 8018144
Drug: Dapsone (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone (100 mg twice weekly)
Trial: 8018144
Drug: Aerosolized pentamidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aerosolized pentamidine (100 mg every 2 weeks)
Trial: 3915459
Drug: Domperidone maleate
RxNorm normalized name: domperidone maleate
DrugBank: Domperidone (DB01184)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Domperidone maleate (20 mg t.i.d.)
Trial: 29439618
Drug: Prolonged GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prolonged GnRH agonist therapy (3 consecutive IM injections of triptorelin 3.75 mg 28 days apart)
Trial: 23544775
Drug: Treatment for
RxNorm normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treatment for depression (specifics not provided, but benzodiazepines were used in 18% of patients)
Trial: 17655565
Drug: Physical exercise
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical exercise therapy (PT)
Trial: 7662225
Drug: enalapril (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: enalapril (20 mg/day)
Trial: 10070170
Drug: irbesartan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: irbesartan (100 mg/day)
Trial: 21966787
Drug: Vaginal tablets
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal tablets (ketoconazole 800 mg + clindamycin 100 mg)
Trial: 21966787
Drug: Vaginal capsules
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal capsules (ketoconazole 800 mg + clindamycin 100 mg)
Trial: 15528908
Drug: Essential oil
RxNorm normalized name: Essential oil
DrugBank: Rosemary oil (DB14689)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential oil mouthrinse plus 100 mg/kg fluoride
Trial: 9286238
Drug: Total paracentesis
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total paracentesis plus intravenous albumin (PARA)
Trial: 20189472
Drug: Metoclopramide hydrochloride
RxNorm normalized name: Metoclopramide Hydrochloride
DrugBank: Metoclopramide (DB01233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metoclopramide hydrochloride tablets
Trial: 18022695
Drug: Urinary N(2)O
RxNorm normalized name: O-2-Naphthyl m,N-dimethylthiocarbanilate
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urinary N(2)O >= 27 microg/l
Trial: 18022695
Drug: Urinary N(2)O
RxNorm normalized name: O-2-Naphthyl m,N-dimethylthiocarbanilate
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Urinary N(2)O < 27 microg/l
Trial: 18022695
Drug: Workers with
RxNorm normalized name: Apis cerana worker secretion preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Workers with urinary N(2)O >= 27 microg/l
Trial: 10628604
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of pancuronium (n = 14)
Trial: 7862660
Drug: Plasma rich
RxNorm normalized name: Platelet Rich Plasma
DrugBank: Platelet Rich Plasma (DB19295)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plasma rich in anti-HIV-1 antibody
Trial: 2029920
Drug: Green light
RxNorm normalized name: light green SF yellowish
DrugBank: Light green SF yellowish (DB11183)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green light phototherapy (Sylvania F20T12/G)
Trial: 19528841
Drug: sugar-free Red
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sugar-free Red Bull energy drink (2 mg x kg(‐1) body mass caffeine or approximately 147 mg caffeine; 4 kcal/250 mL)
Trial: 19528841
Drug: noncaffeinated, sugar-free
FDA approved: no
EMA approved: no
PMDA approved: no
Description: noncaffeinated, sugar-free placebo (lemon-lime flavored soft drink, tonic water, lime juice; 4 kcal/250 mL)
Trial: 17304888
Drug: 2.5% hydrocortisone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% hydrocortisone in moisturizing cream
Trial: 17304888
Drug: Moisturizing cream
RxNorm normalized name: MOISTURIZING CREAM
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moisturizing cream alone
Trial: 15802775
Drug: Various agents
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various agents for treatment and prevention of osteoporosis, specific agents not mentioned, duration not specified.
Trial: 10233200
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg rizatriptan
Trial: 10233200
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg rizatriptan
Trial: 10233200
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg intravenous rizatriptan
Trial: 2383801
Drug: Caffeine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (5 mg/kg body weight followed by 2.5 mg/kg body weight 2 and 0.5 hours before exercise)
Trial: 7054040
Drug: Essential amino
RxNorm normalized name: Essential amino acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Essential amino acids infusion
Trial: 7054040
Drug: Oleic acid
RxNorm normalized name: Oleic Acid
DrugBank: Oleic Acid (DB04224)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oleic acid infusion
Trial: 29108091
Drug: Intravenous low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous low-dose epinephrine (LDEPI) plus tranexamic acid (TXA)
Trial: 29108091
Drug: Topical diluted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diluted epinephrine plus tranexamic acid (TXA)
Trial: 24417761
Drug: Dexmedetomidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexmedetomidine (1 μg · kg(‐1) loading dose over 10 min followed by 0.5 μg · kg(‐1) · h(‐1) infusion)
Trial: 10782589
Drug: Intradermal vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal vaccination (ID) 0.15 mL
Trial: 10782589
Drug: Intramuscular vaccination
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular vaccination (IM) 1.0 mL
Trial: 6813899
Drug: Butoctamide hydrogen
RxNorm normalized name: Hydrogen
DrugBank: Hydrogen (DB15127)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butoctamide hydrogen succinate (BAHS) 600 mg
Trial: 23417317
Drug: Argireline applied
RxNorm normalized name: Argireline NP
DrugBank: Acetyl hexapeptide-3 (DB11709)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argireline applied twice daily for 4 weeks
Trial: 18200995
Drug: Arndt bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arndt bronchial blocker (ABB) for right-sided surgery
Trial: 18200995
Drug: Arndt bronchial
RxNorm normalized name: Bronchitol
DrugBank: Mannitol (DB00742)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Arndt bronchial blocker (ABB) for left-sided surgery
Trial: 14990522
Drug: Cognitive-behavioural therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioural therapy by general practitioners (5 to 7 sessions of 30 minutes each)
Trial: 11548448
Drug: Losartan (50-100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50-100 mg o.d.)
Trial: 10087430
Drug: Warfarin managed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin managed by a nomogram
Trial: 10087430
Drug: Standard warfarin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard warfarin management by attending physicians
Trial: 7921924
Drug: Radiotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy plus continuous oral chlorambucil (RT+CHL)
Trial: 3139463
Drug: Follicle-stimulating hormone
RxNorm normalized name: Follicle-stimulating hormone receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Follicle-stimulating hormone (FSH) (Metrodin, Serono Laboratories, Inc.)
Trial: 31226717
Drug: Guided de-escalation
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guided de-escalation of dual antiplatelet treatment (DAPT)
Trial: 29112565
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation with oral antibiotics
Trial: 21531233
Drug: Bare metal
RxNorm normalized name: menthone 1,2-glycerol ketal, (-)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bare metal stents followed by a 40-day prednisone treatment
Trial: 16436648
Drug: Topiramate (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (400 mg/day target dose)
Trial: 15211369
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg orlistat per day (group 1; n=30)
Trial: 15211369
Drug: 360 mg
RxNorm normalized name: aspirin 360 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 360 mg orlistat plus 1700 mg metformin per day (group 2; n=27)
Trial: 9477041
Drug: Micronized purified
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized purified flavonoid fraction (Daflon 500 mg = Dios), 2 tablets/day for 2 months
Trial: 7888231
Drug: 160 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 160 micrograms rgp160 vaccine
Trial: 7888231
Drug: 640 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 640 micrograms rgp160 vaccine
Trial: 3345623
Drug: Nisoldipine (oral)
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine (oral)
Trial: 3345623
Drug: Nisoldipine (intravenous)
RxNorm normalized name: Nisoldipine
DrugBank: Nisoldipine (DB00401)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nisoldipine (intravenous)
Trial: 21371548
Drug: Gastroretentive tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gastroretentive tablet (GT)
Trial: 21371548
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of GT with CT
Trial: 16741654
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg intravenous thiamine
Trial: 11913310
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 5% sodium bicarbonate (0 times daily - control)
Trial: 11913310
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 5% sodium bicarbonate (1 time daily)
Trial: 11913310
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 5% sodium bicarbonate (2 times daily)
Trial: 11913310
Drug: Chewing gum
RxNorm normalized name: Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewing gum containing 5% sodium bicarbonate (3 times daily)
Trial: 9744587
Drug: Pre and
RxNorm normalized name: MENTHOL 100 mg in 1 g TOPICAL CREAM [Dr. Teals Pre and Post Workout Pain Relief]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pre and post prandial Duplex colour Doppler sonographic measurement of superior mesenteric artery (SMA) flow after a food challenge (200 ml of Ensure Plus)
Trial: 9744587
Drug: Systemic steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Systemic steroids introduced to patients with active Crohn's disease
Trial: 8276648
Drug: LOW instantaneous
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LOW instantaneous dose rate (6 cGy/min single-dose)
Trial: 8276648
Drug: HIGH instantaneous
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HIGH instantaneous dose rate (15 cGy/min single-dose)
Trial: 8276648
Drug: Single-dose total-body
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose total-body irradiation
Trial: 8276648
Drug: Single-dose LOW
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose LOW
Trial: 8276648
Drug: Single-dose HIGH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-dose HIGH
Trial: 2663164
Drug: Ketanserin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketanserin (20 mg twice daily for two weeks, then 40 mg twice daily for three months)
Trial: 2663164
Drug: Methyldopa (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (250 mg twice daily for two weeks, then 500 mg twice daily for three months)
Trial: 8774
Drug: Hypertonic solutions
RxNorm normalized name: Hypertonic solutions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic solutions
Trial: 8774
Drug: Hypertonic non-electrolyte
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic non-electrolyte solutions
Trial: 26852499
Drug: Hyperbaric gaseous
RxNorm normalized name: oxygen
DrugBank: Oxygen (DB09140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperbaric gaseous cryotherapy in addition to traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage.
Trial: 26852499
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional physical therapy, balneotherapy, therapeutic physical exercises, and massage without hyperbaric gaseous cryotherapy).
Trial: 16921043
Drug: Single high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single high-dose chemotherapy (HDT)
Trial: 16921043
Drug: Tandem high-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tandem high-dose chemotherapy (HDT)
Trial: 16921043
Drug: Complete remission
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complete remission after induction chemotherapy
Trial: 15015647
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (3 mg/kg heparin)
Trial: 9167099
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet (30% daily energy intake) with one fish meal daily (3.6 g omega-3/day)
Trial: 9167099
Drug: Low-fat diet
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-fat diet (30% daily energy intake) without fish
Trial: 1350232
Drug: Azelastine, 4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azelastine, 4 mg twice daily
Trial: 21154036
Drug: Dietary supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary supplements to lower homocysteine
Trial: 7745048
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with active agent or placebo placed in the peritoneal cavity
Trial: 19840308
Drug: 308-nm Excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm Excimer laser treatment, applied twice a week for 12 weeks
Trial: 19840308
Drug: Control patches
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control patches (not treated with the 308-nm Excimer laser)
Trial: 19840308
Drug: 308-nm Excimer
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 308-nm Excimer laser treatment
Trial: 18092260
Drug: Infliximab (standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (standard dosage)
Trial: 18092260
Drug: Infliximab (double
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (double dosage)
Trial: 3392233
Drug: Nilvadipine 4
RxNorm normalized name: nilvadipine
DrugBank: Nilvadipine (DB06712)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine 4 mg
Trial: 3229870
Drug: Nilvadipine 12
RxNorm normalized name: nilvadipine
DrugBank: Nilvadipine (DB06712)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine 12 mg
Trial: 3229870
Drug: Nilvadipine 20
RxNorm normalized name: nilvadipine
DrugBank: Nilvadipine (DB06712)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nilvadipine 20 mg
Trial: 31027060
Drug: Mirror Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirror Therapy (MT) for 30 minutes a day, 3 days a week for 4 weeks + conventional physical therapy
Trial: 28652725
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 μg QD
Trial: 24157144
Drug: Multimodal cocktail
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal cocktail periarticular injection with steroid
Trial: 24157144
Drug: Multimodal cocktail
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal cocktail periarticular injection without steroid
Trial: 21916908
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care (counselling on osteoporosis, risk factors, lifestyle modifications, goals of therapy, side effects, and importance of adherence)
Trial: 21916908
Drug: Pharmaceutical care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmaceutical care (counselling)
Trial: 3312450
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (BDP) inhalation aerosol
Trial: 27873451
Drug: Piperacillin/tazobactam (PIPC/TAZ)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piperacillin/tazobactam (PIPC/TAZ) 337.5 mg/kg per day in three doses, 1-hr DIV, maximum 13.5 g per day
Trial: 27873451
Drug: Meropenem (MEPM)
RxNorm normalized name: Meropenem
DrugBank: Meropenem (DB00760)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Meropenem (MEPM) 120 mg/kg per day in three doses, 1-hr DIV, maximum 3 g per day
Trial: 24598216
Drug: Remifentanil with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Remifentanil with an effect-site target concentration of 3 ng/ml
Trial: 12182258
Drug: IV ramosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ramosetron 0.15 mg
Trial: 12182258
Drug: IV ramosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ramosetron 0.3 mg
Trial: 12182258
Drug: IV ramosetron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ramosetron 0.6 mg
Trial: 10448289
Drug: Adjuvant tamoxifen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant tamoxifen (TAM) 20 mg daily for 2 years
Trial: 10448289
Drug: TAM plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAM plus one cycle of low-dose, short-term chemotherapy
Trial: 24849193
Drug: Olmesartan medoxomil/hydrochlorothiazide
RxNorm normalized name: olmesartan medoxomil/hydrochlorothiazide 40 mg-25 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil/hydrochlorothiazide (20/12.5 mg) fixed-dose combination tablet
Trial: 22999396
Drug: Sublingual misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sublingual misoprostol 400μg
Trial: 17543781
Drug: 1.5 mg
RxNorm normalized name: boron 1.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 mg everolimus
Trial: 17543781
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg everolimus
Trial: 15480108
Drug: Aldosterone inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aldosterone inhibitor (amiloride and hydrochlorothiazide)
Trial: 8311218
Drug: Tegaderm dressing
RxNorm normalized name: Tegaderm Dressing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tegaderm dressing with EMLA cream
Trial: 2571116
Drug: Clonidine-desipramine combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine-desipramine combination
Trial: 778302
Drug: Live, attenuated
RxNorm normalized name: Ebola Zaire vaccine (live, attenuated)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Live, attenuated influenza A/England/42/72 (H3N2) vaccine
Trial: 26318350
Drug: Acellular diphtheria-tetanus-pertussis
RxNorm normalized name: DIPHTHERIA/TETANUS/PERTUSSIS VACCINE INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acellular diphtheria-tetanus-pertussis vaccine (at least three doses)